Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp cut its holdings in Centene Corp (NYSE:CNC) by 2.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 176,400 shares of the company’s stock after selling 4,000 shares during the period. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned about 0.10% of Centene worth $17,795,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. BlackRock Inc. boosted its holdings in shares of Centene by 4.6% in the 4th quarter. BlackRock Inc. now owns 13,939,406 shares of the company’s stock valued at $1,406,209,000 after buying an additional 616,914 shares during the period. Ameriprise Financial Inc. boosted its stake in Centene by 47.8% during the 3rd quarter. Ameriprise Financial Inc. now owns 5,181,047 shares of the company’s stock valued at $502,999,000 after purchasing an additional 1,676,688 shares during the period. Dimensional Fund Advisors LP boosted its stake in Centene by 6.7% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,398,997 shares of the company’s stock valued at $232,137,000 after purchasing an additional 149,743 shares during the period. Geode Capital Management LLC boosted its stake in Centene by 3.3% during the 4th quarter. Geode Capital Management LLC now owns 2,252,890 shares of the company’s stock valued at $226,889,000 after purchasing an additional 72,566 shares during the period. Finally, Deutsche Bank AG boosted its stake in Centene by 19.1% during the 4th quarter. Deutsche Bank AG now owns 1,775,194 shares of the company’s stock valued at $179,077,000 after purchasing an additional 284,620 shares during the period. 90.52% of the stock is owned by institutional investors and hedge funds.
Shares of Centene stock opened at $104.69 on Thursday. The firm has a market cap of $18,167.01, a P/E ratio of 20.61, a PEG ratio of 1.00 and a beta of 0.76. Centene Corp has a one year low of $65.03 and a one year high of $112.42. The company has a quick ratio of 0.93, a current ratio of 0.93 and a debt-to-equity ratio of 0.68.
Centene (NYSE:CNC) last issued its quarterly earnings results on Tuesday, February 6th. The company reported $0.97 earnings per share for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. The company had revenue of $12.81 billion during the quarter, compared to analyst estimates of $12.25 billion. Centene had a net margin of 1.71% and a return on equity of 13.68%. The business’s revenue for the quarter was up 7.5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.19 EPS. research analysts anticipate that Centene Corp will post 7.2 earnings per share for the current year.
In other news, EVP Christopher D. Bowers sold 4,800 shares of the company’s stock in a transaction that occurred on Monday, March 12th. The shares were sold at an average price of $102.27, for a total value of $490,896.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Robert K. Ditmore sold 8,750 shares of the company’s stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $104.30, for a total transaction of $912,625.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 27,300 shares of company stock valued at $2,815,209. Company insiders own 3.00% of the company’s stock.
CNC has been the subject of a number of analyst reports. Zacks Investment Research raised shares of Centene from a “hold” rating to a “strong-buy” rating and set a $117.00 target price for the company in a research note on Tuesday, December 26th. Oppenheimer boosted their target price on shares of Centene from $111.00 to $122.00 and gave the company an “outperform” rating in a research note on Wednesday, December 20th. Jefferies Group boosted their target price on shares of Centene from $112.00 to $115.00 and gave the company a “buy” rating in a research note on Monday, December 18th. Piper Jaffray Companies reissued a “buy” rating and set a $134.00 target price on shares of Centene in a research note on Monday, December 18th. Finally, ValuEngine raised shares of Centene from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Three analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. Centene currently has an average rating of “Buy” and a consensus price target of $110.28.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.thelincolnianonline.com/2018/03/22/centene-corp-cnc-shares-sold-by-her-majesty-the-queen-in-right-of-the-province-of-alberta-as-represented-by-alberta-investment-management-corp.html.
Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.